COVID-19 mRNA Vaccine: Mechanism and Immune Response

Added:

Limitations of Systemic mRNA Delivery: Mucosal Immunity and Immune Imprinting

While mRNA vaccines successfully trigger systemic IgG antibody production to prevent severe disease, scientific researchers highlight key limitations in their immunological mechanism. First, systemic intramuscular injection fails to stimulate robust mucosal immunity (secretory IgA) in the upper respiratory tract, which is critical for blocking viral entry and preventing transmission. Second, the phenomenon of "immune imprinting" (or original antigenic sin) suggests that repeated exposure to the initial vaccine's spike protein antigen can restrict the immune system's ability to adapt and respond effectively to rapidly evolving variants. These perspectives argue that the current mRNA mechanism, while effective at preventing systemic illness, is fundamentally limited in achieving long-term, sterilizing immunity compared to mucosal vaccines or natural, broader infection.

The Central Dogma of Molecular Biology, specifically how mRNA is translated into proteins by ribosomes inside host cells.
Basic components of the human immune system, including the distinction between innate and adaptive immunity, and the roles of antigens and antibodies.
General structure of viruses, particularly the function of surface proteins (like the SARS-CoV-2 spike protein) in binding to host cell receptors.
The fundamental concept of immunization and how vaccines historically train the immune system using weakened or inactivated pathogens.
The technology of Lipid Nanoparticles (LNPs) and how they protect and deliver mRNA into host cells without degradation.
A comparative analysis of modern vaccine platforms, including mRNA, adenoviral vectors, protein subunits, and inactivated viruses.
How viral mutations and genetic variants (such as variants of concern) impact spike protein structure and vaccine efficacy.
Future applications of mRNA technology in therapeutics, including cancer vaccines, personalized medicine, and vaccines for other infectious diseases like influenza and HIV.
1.4M views16.1Klikes5:42@nucleusmedicalmediaOriginal Release: 2021-08-03

mRNA vaccines work by delivering genetic instructions to your cells to produce a harmless spike protein found on the coronavirus, which tricks your immune system into creating antibodies and memory cells that recognize and fight the actual virus if you're exposed; this process does not alter your DNA and typically causes mild side effects like soreness, fatigue, or fever as your immune system responds, with full protection developing about two weeks after the second dose.